Metastasis is promoted by a bioenergetic switch: New targets for progressive renal cell cancer
Authors:
Open Access
- 26 February 2008
- journal article
- carcinogenesis
- Published by Wiley in International Journal of Cancer
- Vol. 122 (11) , 2422-2428
Abstract
Targeted therapies have demonstrated clinical benefit with limited impact on long‐term disease specific survival in the treatment of renal cell cancer (RCC). New opportunities for the treatment of tumors that are resistant or have relapsed, are needed. Increased anaerobic glucose fermentation to lactate (aerobic glycolysis), leading to oxygen‐ and mitochondria‐independent ATP generation is a hallmark of aggressive cancer growth. This metabolic shift results in increased lactate production via cycling through the pentose phosphate pathway (PPP), and plays an important role in tumor immune escape, progression and resistance to immune‐, radiation‐ and chemo‐therapy. This study explored the activity and impact of the oxidative and nonoxidative branches of the PPP on RCC to evaluate new therapeutic options. Activity was determined in the oxidative branch by glucose‐6‐phosphate‐dehydrogenase (G6PD) activity, and in the nonoxidative branch by the total transketolase activity and the specific expression of the transketolase‐like‐1 (TKTL1) protein. Transketolase and G6PD activity were intensely elevated in tumor tissues. Transketolase, but not G6PD activity, was more elevated in metastasizing tumors and TKTL1 protein was significantly overexpressed in progressing tumors (p = 0.03). Lethal tumors, where surrogate parameters such as grading and staging had failed to predict progression, showed intensive TKTL1 protein expression. RCC was found to have activated oxidative and nonoxidative glucose metabolism through the PPP, displaying a bioenergetic shift toward nonoxidative glucose fermentation in progressing tumors. The coexistence of cancer cells with differentially regulated energy supplies provides new insights in carcinogenesis and novel anticancer targets.Keywords
This publication has 46 references indexed in Scilit:
- Gastrointestinal stromal tumourThe Lancet, 2007
- The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cellsAnti-Cancer Drugs, 2007
- Lactate and malignant tumors: A therapeutic target at the end stage of glycolysisJournal of Bioenergetics and Biomembranes, 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007
- Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell CarcinomaJournal of Clinical Oncology, 2006
- In Situ Localization of Transketolase Activity in Epithelial Cells of Different Rat Tissues and Subcellularly in Liver Parenchymal CellsJournal of Histochemistry & Cytochemistry, 2006
- The role of carbonic anhydrase IX overexpression in kidney cancerEuropean Journal of Cancer, 2005
- The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinomaCancer, 2004
- Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports.Journal of the American College of Nutrition, 1995
- Enzymology of Cancer CellsNew England Journal of Medicine, 1977